Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0031154 (
peritonitis
)
15,372
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The
glucocorticoid-induced leucine zipper
(
GILZ
) gene is a pivotal mediator of the anti-inflammatory effects of glucocorticoids (GCs) that are known to regulate the function of both adaptive and innate immunity cells. Our aim was to investigate the role of
GILZ
in GC-induced inhibition of neutrophil migration, as this role has not been investigated before. We found that
GILZ
expression was induced by dexamethasone (DEX), a synthetic GC, in neutrophils, and that it regulated migration of these cells into inflamed tissues under DEX treatment. Of note, inhibition of neutrophil migration was not observed in
GILZ
-knockout mice with
peritonitis
that were treated by DEX. This was because DEX was unable to up-regulate annexin A1 (Anxa1) expression in the absence of
GILZ
. Furthermore, we showed that
GILZ
mediates Anxa1 induction by GCs by transactivating Anxa1 expression at the promoter level
via
binding with the transcription factor, PU.1. The present findings shed light on the role of
GILZ
in the mechanism of induction of Anxa1 by GCs. As Anxa1 is an important protein for the resolution of inflammatory response,
GILZ
may represent a new pharmacologic target for treatment of inflammatory diseases.-Ricci, E., Ronchetti, S., Pericolini, E., Gabrielli, E., Cari, L., Gentili, M., Roselletti, E., Migliorati, G., Vecchiarelli, A., Riccardi, C. Role of the
glucocorticoid-induced leucine zipper
gene in dexamethasone-induced inhibition of mouse neutrophil migration
via
control of annexin A1 expression.
...
PMID:Role of the glucocorticoid-induced leucine zipper gene in dexamethasone-induced inhibition of mouse neutrophil migration
via
control of annexin A1 expression. 2837 8